Skip to main content
TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
10.10
+0.05 (0.50%)
May 22, 2025, 1:30 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Development of Innovative New Drugs
119.15M
Log In
Log In
Log In
Log In
Upgrade
Development of Innovative New Drugs Growth
228.87%
Log In
Log In
Log In
Log In
Upgrade
Other
3.99M
Log In
Log In
Log In
Log In
Upgrade
Consultation on Pharmaceutical Technology
-
Log In
Log In
Log In
Log In
Upgrade
Consultation on Pharmaceutical Technology Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
3.99M
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Other
-
Log In
Log In
Log In
Log In
Upgrade
China
92.57M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-
Log In
Log In
Log In
Log In
Upgrade
Taiwan
30.57M
Log In
Log In
Log In
Log In
Upgrade
Taiwan Growth
45.36%
Log In
Log In
Log In
Log In
Upgrade
Russia
-
Log In
Log In
Log In
Log In
Upgrade
South Korea
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade